The Goldman Sachs Group, Inc. 13D and 13G filings for Oaktree Acquisition Corp. III Life Sciences:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-09 12:31 pm Purchase |
2025-03-31 | 13G | Oaktree Acquisition Corp. III Life Sciences OACC |
GOLDMAN SACHS GROUP INC GS |
1,337,502 6.700% |
1,337,502 (New Position) |
Filing |